Literature DB >> 9187225

Phyto-oestrogens and Western diseases.

H Adlercreutz1, W Mazur.   

Abstract

Incidences of breast, colorectal and prostate cancer are high in the Western world compared to countries in Asia. We have postulated that the Western diet compared to the semivegetarian diet in some Asian countries may alter hormone production, metabolism or action at the cellular level by some biochemical mechanisms. Our interest has been focused on two groups of hormone-like diphenolic phyto-oestrogens of dietary origin, the lignans and isoflavonoids abundant in plasma of subjects living in areas with low cancer incidence. The precursors of the biologically active compounds detected in man are found in soybean products, whole-grain cereal food, seeds, and berries. The plant lignan and isoflavonoid glycosides are converted by intestinal bacteria to hormone-like compounds. The weakly oestrogenic diphenols formed influence sex-hormone production, metabolism and biological activity, intracellular enzymes, protein synthesis, growth factor action, malignant cell proliferation, differentiation, cell adhesion and angiogenesis in such a way as to make them strong candidates for a role as natural cancer-protective compounds. Their effect on some of the most important steroid biosynthetic enzymes may result in beneficial modulation of hormone concentrations and action in the cells preventing development of cancer. Owing to their oestrogenic activity they reduce hot flushes and vaginal dryness in postmenopausal women and may to some degree inhibit osteoporosis, but alone they may be insufficient for complete protection. Soy intake prevents oxidation of the low-density lipoproteins in vitro when isolated from soy-treated individuals and affect favourably plasma lipid concentrations. Animal experiments provide evidence suggesting that both lignans and isoflavonoids may prevent the development of cancer as well as atherosclerosis. However, in some of these experiments it has not been possible to separate the phyto-oestrogen effect from the effect of other components in the food. The isoflavonoids and lignans may play a significant inhibitory role in cancer development particularly in the promotional phase of the disease, but recent evidence points also to a role in the initiation stage of carcinogenesis. At present, however, no definite recommendations can be made as to the dietary amounts needed for prevention of disease. This review deals with all the above-mentioned aspects of phyto-oestrogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187225     DOI: 10.3109/07853899709113696

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  155 in total

1.  Effects of chronic dietary exposure to genistein, a phytoestrogen, during various stages of development on reproductive hormones and spermatogenesis in rats.

Authors:  D Roberts; D N Veeramachaneni; W D Schlaff; C A Awoniyi
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 2.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

3.  Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Deborah A Boggs; Lynn Rosenberg
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

4.  Abscisic acid regulates pinoresinol-lariciresinol reductase gene expression and secoisolariciresinol accumulation in developing flax (Linum usitatissimum L.) seeds.

Authors:  Sullivan Renouard; Cyrielle Corbin; Tatiana Lopez; Josiane Montguillon; Laurent Gutierrez; Frédéric Lamblin; Eric Lainé; Christophe Hano
Journal:  Planta       Date:  2011-08-12       Impact factor: 4.116

Review 5.  Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis.

Authors:  Xiyan Mu; Xue Du; Kui Yao; Jitong Zhao; Ce Bian; Qiao Wang; Hongwei Ma; Tao Yi; Yang Wu; Xia Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Free energies of ligand binding for structurally diverse compounds.

Authors:  Chris Oostenbrink; Wilfred F van Gunsteren
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

7.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

8.  Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women.

Authors:  M Atteritano; S Mazzaferro; A Frisina; M L Cannata; A Bitto; R D'Anna; F Squadrito; I Macrì; N Frisina; M Buemi
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

9.  Soy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis.

Authors:  Gong Yang; Xiao Ou Shu; Wong-Ho Chow; Xianglan Zhang; Hong-Lan Li; Bu-Tian Ji; Hui Cai; Shenghui Wu; Yu-Tang Gao; Wei Zheng
Journal:  Am J Epidemiol       Date:  2012-10-24       Impact factor: 4.897

10.  Prediagnosis soy food consumption and lung cancer survival in women.

Authors:  Gong Yang; Xiao-Ou Shu; Hong-Lan Li; Wong-Ho Chow; Wanqing Wen; Yong-Bing Xiang; Xianglan Zhang; Hui Cai; Bu-Tian Ji; Yu-Tang Gao; Wei Zheng
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.